Skip to main content

2 Result(s)

within Peter H. Wiernik Remove this filter Cancer Research Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB)

    The 11 year disease-free and overall survival for 20 previously untreated patients with Hodgkin's disease stages IIIB (10 patients), IVA (2 patients), and IVB (8 patients) treated with a combination of strepto...

    Peter H. Wiernik, Charles A. Schiffer in Journal of Cancer Research and Clinical Oncology (1988)

  2. No Access

    Article

    Acute leukemia in a patient cured of diffuse histiocytic lymphoma

    A patient is described who, after completing treatment for diffuse histiocytic lymphoma, remained disease-free for 7 years (presumably cured), then developed acute nonlymphocytic leukemia (ANLL) after a brief ...

    Janice P. Dutcher, Peter H. Wiernik in Journal of Cancer Research and Clinical Oncology (1986)